EDAP 250117 2.50C (EDAP250117C2500) Stock Options, News & Quotes

0.01
-0.04-80.00%

15min DelayClose Jan 17 16:00 ET

0.05High0.01Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Jaguar8

Jan 12 16:02

🟢 Watchlist JANUARY 13, 2025, Monday. NFA. Those with 🟢 are my top picks

NOTE!
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you don’t a...

Jaguar8

Jan 9 15:27

🔵 Watchlist JANUARY 10,2025, Friday. NFA. Quite long because of Wednesday’s red day and Thursday good news… in progress

109

TiminGila

Jan 8 10:51

$EDAP

$EDAP TMS (EDAP.US)$ EDAP ANNOUNCES FIRST PANCREATIC CANCER PATIENT TREATED WITH PROPRIETARY HIFU TECHNOLOGY

Jaguar8

Jan 8 09:40

NEWS TODAY

$EDAP TMS (EDAP.US)$
EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology
Wednesday, 8th January at 7:00 am
AUSTIN, Texas, January 8, 2025 - EDAP TMS SA (NASDAQ: EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial sponsored by the Centre Léon Bérard, Lyon, France, evaluating proprietary High Intensity Focused Ultrasound (HIFU) technology for the treatment of panc...

Jaguar8

Dec 4, 2024 18:33

NEWS TODAY

$EDAP TMS (EDAP.US)$
Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer
EDAP TMS SA (Nasdaq: EDAP) announced the publication of the HIFI study results in European Urology, comparing Focal One® Robotic HIFU to radical prostatectomy (RP) for localized prostate cancer treatment. The landmark study, involving 3,328 patients across 46 centers, demonstrated that Focal One Robotic HIFU is non-inferior ...